CR11270A - Pirimidinas biciclicas fusionadas - Google Patents

Pirimidinas biciclicas fusionadas

Info

Publication number
CR11270A
CR11270A CR11270A CR11270A CR11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A
Authority
CR
Costa Rica
Prior art keywords
fusioned
pyrimidins
bicycle
tautomers
stereoisomers
Prior art date
Application number
CR11270A
Other languages
English (en)
Inventor
Swen Holder
Matthias Vennemann
Gerrit Beneke
Armin Zulch
Volker Gekeler
Thomas Beckers
Astrid Zimmermann
Hemant Joshi
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07118736A external-priority patent/EP2050748A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR11270A publication Critical patent/CR11270A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compuestos de formula (I) los tautomeros o los estereoisomeros de estos o las sales de estos, donde el anillo B y la pirimidina a la que esta fusionado.
CR11270A 2007-08-14 2010-02-12 Pirimidinas biciclicas fusionadas CR11270A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1572MU2007 2007-08-14
EP07118736A EP2050748A1 (en) 2007-10-18 2007-10-18 Novel fused pyrimidines

Publications (1)

Publication Number Publication Date
CR11270A true CR11270A (es) 2010-05-19

Family

ID=40153211

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11270A CR11270A (es) 2007-08-14 2010-02-12 Pirimidinas biciclicas fusionadas

Country Status (38)

Country Link
US (2) US7776864B2 (es)
EP (1) EP2188291B1 (es)
JP (1) JP5344637B2 (es)
KR (1) KR20100053556A (es)
CN (1) CN101778851B (es)
AR (1) AR067945A1 (es)
AU (1) AU2008288392B2 (es)
BR (1) BRPI0815207A2 (es)
CA (1) CA2694058C (es)
CL (1) CL2008002398A1 (es)
CO (1) CO6260077A2 (es)
CR (1) CR11270A (es)
CY (1) CY1113486T1 (es)
DK (1) DK2188291T3 (es)
DO (1) DOP2010000058A (es)
EA (1) EA020996B1 (es)
EC (1) ECSP109964A (es)
ES (1) ES2396177T3 (es)
HK (1) HK1146273A1 (es)
HN (1) HN2010000313A (es)
HR (1) HRP20121022T1 (es)
IL (1) IL203163A (es)
MA (1) MA31608B1 (es)
MX (1) MX2010001746A (es)
MY (1) MY169738A (es)
NZ (1) NZ583267A (es)
PA (1) PA8793201A1 (es)
PE (1) PE20090944A1 (es)
PL (1) PL2188291T3 (es)
PT (1) PT2188291E (es)
RS (1) RS52559B (es)
SI (1) SI2188291T1 (es)
SV (1) SV2010003483A (es)
TN (1) TN2010000070A1 (es)
TW (1) TWI439272B (es)
UA (1) UA99735C2 (es)
UY (1) UY31293A1 (es)
WO (1) WO2009021992A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009003972A (es) * 2006-10-19 2009-04-27 Takeda Pharmaceutical Compuesto de indol.
EP2188291B1 (en) 2007-08-14 2012-09-19 Bayer Pharma Aktiengesellschaft Fused bicyclic pyrimidines
WO2009155121A2 (en) 2008-05-30 2009-12-23 Amgen Inc. Inhibitors of pi3 kinase
WO2010091808A1 (en) 2009-02-13 2010-08-19 Bayer Schering Pharma Aktiengesellschaft Fused pyrimidines
WO2010091824A1 (en) * 2009-02-13 2010-08-19 Bayer Schering Pharma Aktiengesellschaft Fused pyrimidines as akt inhibitors
EP2413932A4 (en) * 2009-04-01 2012-09-19 Merck Sharp & Dohme INHIBITORS OF AKT ACTIVITY
TW201103943A (en) 2009-04-27 2011-02-01 Shionogi & Co Urea derivative having pi3k inhibitory activity
US20130184273A1 (en) * 2010-07-13 2013-07-18 Bayer Intellectual Property Gmbh Bicyclic pyrimidines
CN103384670B (zh) 2010-07-28 2016-05-25 拜耳知识产权有限责任公司 取代的咪唑并[1,2-b]哒嗪
HUE026323T2 (en) 2011-04-07 2016-05-30 Bayer Ip Gmbh Imidazopyridazines as AKT kinase inhibitors
RU2644769C2 (ru) 2013-01-23 2018-02-14 Астразенека Аб Химические соединения
US20160272861A1 (en) * 2013-03-15 2016-09-22 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
US20140274685A1 (en) 2013-03-15 2014-09-18 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
MX2020002869A (es) 2017-09-15 2020-07-24 Aduro Biotech Inc Compuestos de pirazolopirimidinona y usos de los mismos.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1592624A (zh) 2000-06-30 2005-03-09 惠氏公司 被取代的三唑并嘧啶类化合物作为抗癌药
US7449488B2 (en) * 2002-06-04 2008-11-11 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
JP4616831B2 (ja) 2003-04-24 2011-01-19 メルク・シャープ・エンド・ドーム・コーポレイション Akt活性の阻害剤
JP2007532558A (ja) 2004-04-09 2007-11-15 メルク エンド カムパニー インコーポレーテッド Akt活性の阻害剤
AR050188A1 (es) * 2004-08-03 2006-10-04 Uriach Y Compania S A J Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen
JP2008510823A (ja) * 2004-08-23 2008-04-10 メルク エンド カムパニー インコーポレーテッド Akt活性阻害剤
EP1827436A4 (en) 2004-12-15 2011-08-10 Merck Sharp & Dohme ACTIVITY INHIBITORS AKT
JP5274842B2 (ja) 2004-12-28 2013-08-28 エグゼリクシス, インコーポレイテッド 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター(p70S6K、Akt−1およびAkt−2)としての[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジンまたは[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジン化合物
WO2006091395A2 (en) 2005-02-14 2006-08-31 Merck & Co., Inc. Inhibitors of akt activity
CA2610888C (en) 2005-06-10 2011-02-08 Merck & Co., Inc. Inhibitors of akt activity
EP2188291B1 (en) 2007-08-14 2012-09-19 Bayer Pharma Aktiengesellschaft Fused bicyclic pyrimidines
WO2010091808A1 (en) * 2009-02-13 2010-08-19 Bayer Schering Pharma Aktiengesellschaft Fused pyrimidines

Also Published As

Publication number Publication date
PL2188291T3 (pl) 2013-06-28
SI2188291T1 (sl) 2013-01-31
US8614218B2 (en) 2013-12-24
HRP20121022T1 (hr) 2013-01-31
AU2008288392B2 (en) 2013-10-24
TWI439272B (zh) 2014-06-01
WO2009021992A2 (en) 2009-02-19
JP2010535848A (ja) 2010-11-25
TW200922592A (en) 2009-06-01
EP2188291A2 (en) 2010-05-26
MY169738A (en) 2019-05-14
BRPI0815207A2 (pt) 2017-03-28
SV2010003483A (es) 2010-07-06
EP2188291B1 (en) 2012-09-19
KR20100053556A (ko) 2010-05-20
EA201000298A1 (ru) 2010-10-29
US20090137607A1 (en) 2009-05-28
NZ583267A (en) 2012-03-30
CY1113486T1 (el) 2016-06-22
RS52559B (en) 2013-04-30
AR067945A1 (es) 2009-10-28
CA2694058C (en) 2016-06-07
WO2009021992A3 (en) 2009-04-16
HK1146273A1 (en) 2011-05-20
HN2010000313A (es) 2013-03-18
MX2010001746A (es) 2010-03-10
DOP2010000058A (es) 2010-02-28
IL203163A (en) 2015-01-29
UA99735C2 (uk) 2012-09-25
PT2188291E (pt) 2012-12-20
AU2008288392A1 (en) 2009-02-19
MA31608B1 (fr) 2010-08-02
CO6260077A2 (es) 2011-03-22
CL2008002398A1 (es) 2009-07-31
DK2188291T3 (da) 2013-01-07
PA8793201A1 (es) 2009-04-23
US7776864B2 (en) 2010-08-17
TN2010000070A1 (en) 2011-09-26
CN101778851B (zh) 2013-05-08
UY31293A1 (es) 2009-03-31
EA020996B1 (ru) 2015-03-31
ES2396177T3 (es) 2013-02-19
CN101778851A (zh) 2010-07-14
JP5344637B2 (ja) 2013-11-20
US20100184782A1 (en) 2010-07-22
PE20090944A1 (es) 2009-08-09
ECSP109964A (es) 2010-03-31
CA2694058A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
CR11270A (es) Pirimidinas biciclicas fusionadas
CY1112102T1 (el) Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1
CR11271A (es) Imidazoles fusionados para el tratamiento del cancer
CO6321272A2 (es) Fosfatos ciclicos de nucleosidos.
CU23834B1 (es) Compuestos de pirazolo [3,4-d] pirimidinona y sus derivados para la inhibición pde9
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
UY28290A1 (es) Compuestos farmacéuticos novedosos
CU20090017A7 (es) Peptidomimeticos de smac utiles como inhibidores de proteinas de apoptosis (iap)
NI200900032A (es) Compuestos de pirido (2, 3-d) pirimidinonay su uso como inhibidores de pi3
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
GT200500286A (es) Analogos de anilino-pirimidina
CO6491082A2 (es) Derivados de n 1-sulfonil-5-fluoropirimidinona
NI201000059A (es) Inhibidores de la cinasa c-fms.
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
DOP2011000174A (es) Compuestos organicos
SV2011003809A (es) Derivados de heteroarilo como inhibidores de dgat1
EA200802380A1 (ru) Совместные кристаллы пирролидинонов
NI200900155A (es) COMPUESTOS DE 2-AMINO PIRIMIDINA. Caso: PC 33441A
UY29070A1 (es) Enantiómeros de heterocíclicos fusionados y sus usos
EA201100994A1 (ru) Способ получения производных бисфуранового спирта, соединения, соль, фармацевтическая композиция на ее основе, способ лечения или профилактики ретровирусных инфекций с ее помощью
EA200900946A1 (ru) Новый способ синтеза агомелатина
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
CR11463A (es) Compuestos de piridilmetil-sulfonamida
ECSP12011652A (es) Derivados de 5-fluoro-2-oxopirimidinona-1 (2h)-carboxamida substituida-n1
UY30788A1 (es) Compuestos quimicos